Investing Profile

Liam Ratcliffe

InvestorVCAngel
Head of Biotechnology at Access Biotechnology
accessbio-tech.comNew York, New York
Photo of Liam Ratcliffe, Investor at Access Biotechnology

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
21
CompanyStageDateRound SizeTotal Raised
Draig Therapeutics
Series AJun 2025$140M
$140M
Eliem Therapeutics
Series BMay 2021$60M
Series AMar 2021$80M
$260M
Co-investors: Ohad Hammer (Pontifax Venture Capital)
Shoopy
SeedFeb 2021$250K
$250K
Passage Bio
Series BSep 2019$110M
Series AFeb 2019$120M
$230M
Co-investors: Carl Gordon (OrbiMed), Patrick Heron (Frazier Healthcare Partners)
CuraSen Therapeutics
Series AOct 2018$55M
$55M
Arvinas
Series CApr 2018$55M
Series BOct 2015$42M
$140M
Co-investors: Kush Parmar (5am Ventures), Stephen Squinto (OrbiMed), Martin Alexander Gershon (Endeavor Venture Funds), Jakob Loven (Nextech Invest), Daniel Wagner (Connecticut Innovations)
Aptinyx
Series BDec 2017$70M
Series AMay 2016$65M
$140M
Co-investors: Adam Koppel (Bain Capital Life Sciences)
Neuronetics
Series GJun 2017$15M
Series FApr 2015$34M
Series EMay 2011$30M
Series DOct 2009$30M
$110M